Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/53182
COMPARTIR / EXPORTAR:
SHARE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis |
Autor: | Teruel, María; Simeón, Carmen P.; Broen, Jasper C.; Vonk, Madelon C.; Carreira, P.; Camps, M. T.; García-Portales, Rosa; Delgado-Frías, Esmeralda; Gallego, María; Espinosa, Gerard; Spanish Scleroderma Group; Beretta, L.; Airó, Paolo; Lunardi, C.; Riemekasten, G.; Witte, Torsten; Krieg, Thomas; Kreuter, A.; Distler, J. H.; Hunzelmann, Nicolas; Koeleman, B. P.; Voskuyl, Alexandre E.; Schuerwegh, A. J.; González-Gay, M. A.; Radstake, T. R.; Martín, J. | Fecha de publicación: | 25-jun-2012 | Editor: | BioMed Central | Citación: | Arthritis Research & Therapy 14(3) : R154- (2012) | Resumen: | Abstract Introduction The aim of the present study was to investigate the possible role of CD40 and CD40 ligand (CD40LG) genes in the susceptibility and phenotype expression of systemic sclerosis (SSc). Methods In total, 2,670 SSc patients and 3,245 healthy individuals from four European populations (Spain, Germany, The Netherlands, and Italy) were included in the study. Five single-nucleotide polymorphisms (SNPs) of CD40 (rs1883832, rs4810485, rs1535045) and CD40LG (rs3092952, rs3092920) were genotyped by using a predesigned TaqMan allele-discrimination assay technology. Meta-analysis was assessed to determine whether an association exists between the genetic variants and SSc or its main clinical subtypes. Results No evidence of association between CD40 and CD40LG genes variants and susceptibility to SSc was observed. Similarly, no significant statistical differences were observed when SSc patients were stratified by the clinical subtypes, the serologic features, and pulmonary fibrosis. Conclusions Our results do not suggest an important role of CD40 and CD40LG gene polymorphisms in the susceptibility to or clinical expression of SSc. | URI: | http://hdl.handle.net/10261/53182 | Identificadores: | http://dx.doi.org/10.1186/ar3890 |
Aparece en las colecciones: | (IPBLN) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
ar3890.xml | 78,9 kB | XML | Visualizar/Abrir | |
ar3890.pdf | 175,48 kB | Adobe PDF | Visualizar/Abrir | |
AR3890-S1.DOC | 323 kB | Microsoft Word | Visualizar/Abrir |
CORE Recommender
Page view(s)
461
checked on 18-mar-2024
Download(s)
677
checked on 18-mar-2024
Google ScholarTM
Check
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.